Enzyme May Impair Recovery From Spinal Cord Injury

This article originally appeared here.
Share this content:
Enzyme May Impair Recovery From Spinal Cord Injury
Enzyme May Impair Recovery From Spinal Cord Injury

TUESDAY, Oct. 28, 2014 (HealthDay News) -- The presence of the enzyme matrix metalloproteinase-3 (MMP-3) may play a key role in worsening spinal cord injury (SCI) and impairing long-term neurological recovery, according to research published in the November issue of The American Journal of Pathology.

Jee Youn Lee, M.D., of the Kyung Hee University School of Medicine in Seoul, South Korea, and colleagues studied the effects of MMP-3 on SCI and recovery in a mouse model.

The researchers found that MMP-3 was induced in infiltrated neutrophils and blood vessels following SCI. Following SCI, blood-spinal cord barrier (BSCB) permeability and blood cell infiltration were more reduced in Mmp3 knockout (KO) mice than in wild-type (WT) mice. This effect was significantly inhibited by Mmp3 siRNA or N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid, a general inhibitor of MMPs. MMP-3 injection into normal spinal cord also induced BSCB permeability. In Mmp3 KO mice, compared with WT mice, greater functional recovery was observed.

"These results demonstrated the role of MMP-3 in BSCB disruption after SCI for the first time and suggest that the regulation of MMP-3 can be considered a therapeutic target to inhibit BSCB disruption and hemorrhage, and thereby enhance functional recovery after acute SCI," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »